Corsera Health Launches with $50M Funding for Preventive Cardiovascular RNAi Program Advancing to Clinic
Corsera Health launched to extend healthspan by predicting and preventing cardiovascular disease using AI and RNAi technologies.
The company raised $50M in funding.
Founders include industry veterans Clive Meanwell and John Maraganore.
A preventive RNAi medicine program for cardiovascular disease is advancing into the clinic by the end of 2025.
Features a predictive AI tool for heart disease alongside the once-annual preventive candidate.